Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) has opened three The Botanist-branded cannabis dispensaries in New York and Ohio. Following the development, Acreage now owns or has management services agreements in place for 23 dispensaries that are currently open in 11 states.
High Hampton Holdings (CSE: HC) (FSE: 0HCN) has signed a binding letter of intent for a minority investment in 2083 Group, which owns and operates a number of consumer-facing companies in the cannabis space.
Abacus Health Products (CSE: ABCS) has received its first purchase order from a major U.S. retail chain. For the first time, the CBDMEDIC family of pain relief and skincare products is going to be available to consumers in a retail store format, according to the company.
Canopy Growth (TSX: WEED) (NYSE: CGC) and Sequential Brands Group (NASDAQ: SQBG) have formed a partnership with Emmy Award-winning television show host Martha Stewart who will work as an advisor to assist launching a new line of product offerings across multiple categories. Canopy, which has developed product offerings specific to hemp-derived CBD, will work closely with Stewart as it further develops and introduces these products to market in the future.
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) has entered into a supply and loan agreement with Canntab Therapeutics and World Class Extractions to purchase hemp flower from Thomas Elcome. Under to the agreement, Thomas Elcome grants Canntab and World Class Extractions the right and option to purchase up to C$5 million of its hemp crop for a period of five years commencing in 2019 at a purchase price of C$100.0 per kg per 1% of CBD extracted from the flower.
Nevada cannabis firm Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) has begun construction on a coffee shop and bistro/pizzeria as part of a phase II expansion of the SuperStore Entertainment Complex, adjacent to the famed Las Vegas Strip. The coffee shop and bistro/pizzeria will help the company capture revenue from non-cannabis consumers and to drive cross-over revenue from cannabis customers. It is only the first of several planned expansions for the 112,000-sq.-ft. site.
AgraFlora Organics International (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF) has issued an update to recent corporate activities and to the previously-announced equity participation and earn-in agreement with Delta Organic Cannabis for up to a $40 million investment at $0.45 per share for the retrofit of a large-scale medical cannabis cultivation operation in Delta, British Columbia.